Bull and Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the substitution mechanic worked through the disposables ban, but FY25 acquisition-adjusted free cash flow of negative £3.65m was real, the H1 FY26 print is the gating data point, and a 56% controlling founder on a one-year SIP with no internal audit raises the bar for ownership without confirmation. Bull carries more weight on operating evidence: 31.9% all-time-high gross margin, vape +13% YoY through the pod transition, 0.3x net leverage. Bear carries weight on the cash-quality and governance ledger that the bull does not address head-on. The deciding tension is the FY25 £25.6m of acquisition spend that nearly equals the £25.1m of CFO — both sides agree on the number; they disagree on whether it is a flywheel or a financing tell. The H1 FY26 release (late November 2025) — DSO and acquisition-adjusted FCF specifically — is what flips the verdict.

Bull Case

Bull's price target is £2.40 on a 12x P/E (the 5-year mean) applied to FY26 EPS of £0.20, with cross-checks to £2.62 on EV/EBITDA reversion to 7.65x and the £2.25-2.29 sell-side band. Timeline: 12-15 months. Disconfirming signal: FY26 vape revenue down more than 25% YoY, or DSO holding above 65 days at the H1 FY26 print, signaling that the receivables build is structural rather than acquisition-timing.

Bear Case

Bear's downside target is £1.05 on a stressed sum-of-the-parts (vape £15m EBITDA × 4x post-October-2026 levy, drinks £11m × 8x, electricals £9m × 5x, less £12m net debt and a £15m goodwill haircut on Clearly Drinks), cross-checked at 7x stressed FY27 EPS of £0.15. Timeline: 12-15 months through the H1 FY26 print, FY26 full year, and the October 2026 vape levy enactment. Cover signal: non-vape gross profit run-rates above £40m on the FY26 print and acquisition-adjusted FCF returns to positive £10m+.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries the operating debate: a 31.9% all-time-high gross margin, vape +13% YoY through the disposables ban, 0.3x net leverage, and a 36% mean-reversion gap on a five-year multiple history are not an accident. Bear carries the cash-quality and governance debate: FY25 acquisition-adjusted FCF of negative £3.65m, a £2.9m bargain-purchase gain inside the bonus formula, and an 11-year audit relationship with no internal audit are not things the bull rebuts. The deciding tension is the £25.6m of FY25 acquisition spend that nearly matches £25.1m of CFO — both sides own the same number and read it differently. The bear could still be right if the H1 FY26 print shows DSO holding above 60 days and another year-end cash draw, because that confirms the flywheel is debt-financed rather than cash-financed. The verdict flips to Lean Long on H1 FY26 acquisition-adjusted FCF turning positive and DSO returning to the high-50s; it flips to Avoid on a third consecutive working-capital draw or a differential vape-levy on refillable pods in the October 2026 Budget.